Clinical Trials In Baltimore

Discover hundreds of clinical trials in Baltimore.
Search clinical trials in Baltimore by condition or phase.

e.g. Respiratory Diseases

Baltimore•Healthy volunteers: No

Filter results

Results: 2,171

Spironolactone for Pulmonary Arterial Hypertension

Recruiting

Phase 2

Sponsor:

NIH

Location:

Bethesda

Code:

NCT01712620

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Placebo

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Recruiting

Phase 2

Sponsor:

CARGO Therapeutics

Location:

Baltimore, Bethesda, Little Rock, Duarteshow 23 more

Code:

NCT05972720

Conditions

Cancer

Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludarabine (Conditional therapy)

Cyclophosphamide Monohydrate (Conditional therapy)

firi-cel (Experimental drug)

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

Phase 2

Sponsor:

Evommune, Inc.

Location:

White Marsh, Birmingham, Los Angeles, San Diegoshow 11 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Recruiting

Phase 2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Baltimore

Code:

NCT02451982

Conditions

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

GVAX pancreatic cancer

Nivolumab

Urelumab

BMS-986253

A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia

Recruiting

Sponsor:

NIH

Location:

Bethesda

Code:

NCT05663320

Conditions

Congenital Adrenal Hyperplasia

Eligibility Criteria

Sex: All

Age: 16 - 22

Healthy Volunteers: Not accepted

Interventions

virtual educational based transition intervention self-paced

Whole Genome Medical Sequencing for Genome Discovery

Recruiting

Sponsor:

National Human Genome Research Institute (NHGRI)

Location:

Bethesda

Code:

NCT01087320

Conditions

Intellectual Disabilities

Congenital Anomaly

Rare Disorders

Eligibility Criteria

Sex: All

Age: 4 - 70+

Healthy Volunteers: Not accepted

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Recruiting

Phase 3

Sponsor:

H. Lundbeck A/S

Location:

Baltimore, Stamford, Gulf Breeze, Hialeahshow 10 more

Code:

NCT05897320

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Eptinezumab

Placebo

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Baltimore, Dothan, Phoenix, Springdaleshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

Phase 3

Sponsor:

Novartis Pharmaceuticals

Location:

Lutherville, Bethesda, Phoenix, Scottsdaleshow 60 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda, Cincinnati, Columbus, West Chester

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

e.g. Respiratory Diseases

Baltimore•Healthy volunteers: No

Filter results

Results: 2,171

Spironolactone for Pulmonary Arterial Hypertension

Recruiting

Phase 2

Sponsor:

NIH

Location:

Bethesda

Code:

NCT01712620

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Placebo

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Recruiting

Phase 2

Sponsor:

CARGO Therapeutics

Location:

Baltimore, Bethesda, Little Rock, Duarteshow 23 more

Code:

NCT05972720

Conditions

Cancer

Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludarabine (Conditional therapy)

Cyclophosphamide Monohydrate (Conditional therapy)

firi-cel (Experimental drug)

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

Phase 2

Sponsor:

Evommune, Inc.

Location:

White Marsh, Birmingham, Los Angeles, San Diegoshow 11 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Recruiting

Phase 2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Baltimore

Code:

NCT02451982

Conditions

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

GVAX pancreatic cancer

Nivolumab

Urelumab

BMS-986253

A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia

Recruiting

Sponsor:

NIH

Location:

Bethesda

Code:

NCT05663320

Conditions

Congenital Adrenal Hyperplasia

Eligibility Criteria

Sex: All

Age: 16 - 22

Healthy Volunteers: Not accepted

Interventions

virtual educational based transition intervention self-paced

Whole Genome Medical Sequencing for Genome Discovery

Recruiting

Sponsor:

National Human Genome Research Institute (NHGRI)

Location:

Bethesda

Code:

NCT01087320

Conditions

Intellectual Disabilities

Congenital Anomaly

Rare Disorders

Eligibility Criteria

Sex: All

Age: 4 - 70+

Healthy Volunteers: Not accepted

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Recruiting

Phase 3

Sponsor:

H. Lundbeck A/S

Location:

Baltimore, Stamford, Gulf Breeze, Hialeahshow 10 more

Code:

NCT05897320

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Eptinezumab

Placebo

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Baltimore, Dothan, Phoenix, Springdaleshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

Phase 3

Sponsor:

Novartis Pharmaceuticals

Location:

Lutherville, Bethesda, Phoenix, Scottsdaleshow 60 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda, Cincinnati, Columbus, West Chester

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging